Search research articles
Contact Us
Filters
Showing results (301-310 of 743) with videos related to
Page
of 75
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 1, 1987
Phase I trial of combination therapy of cancer with N-phosphonacetyl-L-aspartic acid and dipyridamole
M Markman, T C Chan, S Cleary, et al.
Analytical Biochemistry
|
May 1, 1982
Determination of plasma hypoxanthine: a comparison of high-pressure liquid chromatographic and oxygen consumption methods
O D Saugstad, W E Wung, S B Howell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1984
Totally implantable system for peritoneal access
C E Pfeifle, S B Howell, M Markman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2009
Copper transporter 2 regulates the cellular accumulation and cytotoxicity of Cisplatin and Carboplatin
Brian G Blair, Christopher A Larson, Roohangiz Safaei, et al.
Cancer Chemotherapy and Pharmacology
|
August 18, 2009
Preclinical efficacy studies of a novel nanoparticle-based formulation of paclitaxel that out-performs Abraxane
Zhongling Feng, Gang Zhao, Lei Yu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 2, 2002
The cellular pharmacology of oxaliplatin resistance
M Mishima, G Samimi, A Kondo, et al.
Molecular Pharmaceutics
|
October 13, 2011
Effects of solution concentration on the physicochemical properties of a polymeric anticancer therapeutic
Lili X Peng, Lei Yu, Stephen B Howell, et al.
Journal of Chemical Information and Modeling
|
October 15, 2011
Aggregation properties of a polymeric anticancer therapeutic: a coarse-grained modeling study
Lili X Peng, Lei Yu, Stephen B Howell, et al.
Cancer Research
|
December 15, 1994
Cross-resistance between cisplatin and antimony in a human ovarian carcinoma cell line
P Naredi, D D Heath, R E Enns, et al.
Cancer Treatment Reports
|
September 1, 1982
High-dose allopurinol modulation of 5-FU toxicity: phase I trial of an outpatient dose schedule
T N Campbell, S B Howell, C Pfeifle, et al.
Page
of 75
Search research articles
Search
Showing results (301-310 of 743) with videos related to
Sort By:
Page
of 75
Cancer Chemotherapy and Pharmacology
|
January 1, 1987
Phase I trial of combination therapy of cancer with N-phosphonacetyl-L-aspartic acid and dipyridamole
M Markman, T C Chan, S Cleary, et al.
Analytical Biochemistry
|
May 1, 1982
Determination of plasma hypoxanthine: a comparison of high-pressure liquid chromatographic and oxygen consumption methods
O D Saugstad, W E Wung, S B Howell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1984
Totally implantable system for peritoneal access
C E Pfeifle, S B Howell, M Markman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2009
Copper transporter 2 regulates the cellular accumulation and cytotoxicity of Cisplatin and Carboplatin
Brian G Blair, Christopher A Larson, Roohangiz Safaei, et al.
Cancer Chemotherapy and Pharmacology
|
August 18, 2009
Preclinical efficacy studies of a novel nanoparticle-based formulation of paclitaxel that out-performs Abraxane
Zhongling Feng, Gang Zhao, Lei Yu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 2, 2002
The cellular pharmacology of oxaliplatin resistance
M Mishima, G Samimi, A Kondo, et al.
Molecular Pharmaceutics
|
October 13, 2011
Effects of solution concentration on the physicochemical properties of a polymeric anticancer therapeutic
Lili X Peng, Lei Yu, Stephen B Howell, et al.
Journal of Chemical Information and Modeling
|
October 15, 2011
Aggregation properties of a polymeric anticancer therapeutic: a coarse-grained modeling study
Lili X Peng, Lei Yu, Stephen B Howell, et al.
Cancer Research
|
December 15, 1994
Cross-resistance between cisplatin and antimony in a human ovarian carcinoma cell line
P Naredi, D D Heath, R E Enns, et al.
Cancer Treatment Reports
|
September 1, 1982
High-dose allopurinol modulation of 5-FU toxicity: phase I trial of an outpatient dose schedule
T N Campbell, S B Howell, C Pfeifle, et al.
Page
of 75